T1	Procedure 127 148	radical prostatectomy
T2	Procedure-Name 127 148	radical prostatectomy
E1	Procedure:T1 Name:T2
T9	Eq-Operator 205 207	<=
A1	Eq-Operator-Value T9 LTEQ
T10	Eq-Operator 290 296	within
A2	Eq-Operator-Value T10 LTEQ
T11	Eq-Operator 355 356	≥
A3	Eq-Operator-Value T11 GTEQ
T12	Eq-Operator 382 383	≥
A4	Eq-Operator-Value T12 GTEQ
T13	Eq-Operator 412 413	≥
A5	Eq-Operator-Value T13 GTEQ
T14	Eq-Operator 466 472	within
A6	Eq-Operator-Value T14 LTEQ
T15	Eq-Operator 510 511	<
A7	Eq-Operator-Value T15 LT
T19	Eq-Temporal-Unit 299 305	months
A11	Eq-Temporal-Unit-Value T19 month
T20	Eq-Temporal-Unit 475 481	months
A12	Eq-Temporal-Unit-Value T20 month
T22	Eq-Unit 362 367	cells
T23	Eq-Unit 397 400	mm3
T24	Eq-Operator 248 249	-
A14	Eq-Operator-Value T24 BETWEEN
T25	Eq-Value 191 194	0.2
T26	Eq-Value 247 248	0
T27	Eq-Value 249 250	1
T28	Eq-Value 297 298	6
T29	Eq-Value 357 361	1500
T30	Eq-Value 384 390	50,000
T31	Eq-Value 414 417	8.0
T32	Eq-Value 473 474	6
T37	Eq-Comparison 290 305	within 6 months
E8	Eq-Comparison:T37 Operator:T10 Temporal-Unit:T19 Value:T28
T38	Eq-Comparison 355 371	≥ 1500 cells/mm3
E9	Eq-Comparison:T38 Operator:T11 Value:T29 Unit:T22 Per:T74
T39	Eq-Comparison 382 400	≥ 50,000 cells/mm3
E10	Eq-Comparison:T39 Operator:T12 Value:T30 Unit:T76 Per:T23
T40	Eq-Comparison 412 422	≥ 8.0 g/dl
E11	Eq-Comparison:T40 Operator:T13 Value:T31 Unit:T81 Per:T82
T41	Eq-Comparison 466 481	within 6 months
E12	Eq-Comparison:T41 Operator:T14 Temporal-Unit:T20 Value:T32
T44	Eq-Comparison 247 250	0-1
E15	Eq-Comparison:T44 Operator:T24 Value:T26 Value2:T27
T45	Condition 77 92	prostate cancer
E2	Condition:T45 Name:T46
T46	Condition-Name 77 92	prostate cancer
T47	Risk 72 76	risk
E4	Risk:T47 Risk-For:E2 Polarity:T48
T48	Polarity 67 71	high
A15	Polarity-Value T48 high
T49	Polarity 50 62	intermediate
A16	Polarity-Value T49 medium
T50	Or 64 66	or
E6	Or:T50 Arg:T49 Arg2:T48
T51	Procedure 25 39	Pathologically
E16	Procedure:T51 Name:T52
T52	Procedure-Name 25 39	Pathologically
R1	Found-By Arg1:E2 Arg2:E16	
T53	Coreference 110 120	recurrence
E17	Coreference:T53 Refers-To:E2
T54	Temporal-Connection 121 126	after
E18	Temporal-Connection:T54 Arg:E17 Arg2:E1
A17	Temporal-Connection-Type-Value E18 after
T55	Observation 182 185	PSA
E19	Observation:T55 Name:T56 Eq-Comparison:E20 Polarity:T66
T56	Observation-Name 182 185	PSA
A18	Observation-Type-Value T56 lab
T57	Eq-Comparison 186 200	over 0.2 ng/mL
E20	Eq-Comparison:T57 Value:T25 Operator:T60 Unit:T58 Per:T59
T58	Eq-Unit 195 197	ng
T59	Eq-Unit 198 200	mL
T60	Eq-Operator 186 190	over
A19	Eq-Operator-Value T60 GT
T61	Eq-Comparison 205 216	<=1.0 ng/mL
E21	Eq-Comparison:T61 Value:T62 Operator:T9 Unit:T63 Per:T64
T62	Eq-Value 207 210	1.0
T63	Eq-Unit 211 213	ng
T64	Eq-Unit 214 216	mL
T65	And 201 204	and
E22	And:T65 Arg:E20 Arg2:E21
T66	Polarity 169 178	elevation
A20	Polarity-Value T66 high
R2	Equivalent-To Arg1:E19 Arg2:E17	
T67	Observation 223 246	ECOG performance status
E23	Observation:T67 Name:T68 Eq-Comparison:E15
T68	Observation-Name 223 246	ECOG performance status
A21	Observation-Type-Value T68 clinical-score
T69	Study 312 322	enrollment
E24	Study:T69 
T70	Observation 323 348	Absolute neutrophil count
E25	Observation:T70 Name:T71 Eq-Comparison:E8
T71	Observation-Name 323 348	Absolute neutrophil count
A22	Observation-Type-Value T71 lab
T72	Observation 350 353	ANC
E26	Observation:T72 Name:T73 Eq-Comparison:E9
T73	Observation-Name 350 353	ANC
A23	Observation-Type-Value T73 lab
R3	Abbrev-Of Arg1:E26 Arg2:E25	
T74	Eq-Unit 368 371	mm3
T75	Temporal-Connection 306 311	after
E27	Temporal-Connection:T75 Arg:E25 Arg2:E24 Arg3:E8
A24	Temporal-Connection-Type-Value E27 after
T76	Eq-Unit 391 396	cells
T77	Observation 372 381	Platelets
E28	Observation:T77 Name:T78 Eq-Comparison:E10 Temporality:E8
T78	Observation-Name 372 381	Platelets
A25	Observation-Type-Value T78 lab
T79	Observation 401 411	Hemoglobin
E29	Observation:T79 Name:T80 Temporality:E8 Eq-Comparison:E11
T80	Observation-Name 401 411	Hemoglobin
A26	Observation-Type-Value T80 lab
T81	Eq-Unit 418 419	g
T82	Eq-Unit 420 422	dl
T83	Study 488 498	enrollment
E30	Study:T83 
T84	Temporal-Connection 482 487	after
E31	Temporal-Connection:T84 Arg:E12 Arg2:E30
A27	Temporal-Connection-Type-Value E31 after
T85	Observation 450 465	kidney function
E32	Observation:T85 Name:T86 Temporality:E12
T86	Observation-Name 450 465	kidney function
A28	Observation-Type-Value T86 lab
T87	Observation 499 509	Creatinine
E33	Observation:T87 Name:T88 Eq-Comparison:E3 Temporality:E12
T88	Observation-Name 499 509	Creatinine
A29	Observation-Type-Value T88 lab
T3	Eq-Comparison 510 521	< 2.0 ng/dL
E3	Eq-Comparison:T3 Operator:T15 Value:T6 Unit:T4 Per:T5
T4	Eq-Unit 516 518	ng
T5	Eq-Unit 519 521	dL
T6	Eq-Value 512 515	2.0
R4	Equivalent-To Arg1:E33 Arg2:E32	
T7	Observation 549 563	liver function
E5	Observation:T7 Name:T8 Temporality:E13
T8	Observation-Name 549 563	liver function
A8	Observation-Type-Value T8 lab
T16	Study 586 596	enrollment
E7	Study:T16 
T17	Eq-Comparison 564 579	within 6 months
E13	Eq-Comparison:T17 Temporal-Unit:T33 Operator:T18 Value:T21
T18	Eq-Operator 564 570	within
A9	Eq-Operator-Value T18 LTEQ
T21	Eq-Value 571 572	6
T33	Eq-Temporal-Unit 573 579	months
A10	Eq-Temporal-Unit-Value T33 month
T34	Temporal-Connection 580 585	after
E14	Temporal-Connection:T34 Arg:E13 Arg2:E7
A13	Temporal-Connection-Type-Value E14 after
T35	Observation 597 612	total bilirubin
E34	Observation:T35 Name:T36 Eq-Comparison:E35 Temporality:E13
T36	Observation-Name 597 612	total bilirubin
A30	Observation-Type-Value T36 lab
T42	Eq-Comparison 613 641	< 1.5 X maximum normal value
E35	Eq-Comparison:T42 Operator:T43 Value:T89 Unit:T90
T43	Eq-Operator 613 614	<
A31	Eq-Operator-Value T43 LT
T89	Eq-Value 615 618	1.5
T90	Eq-Unit 621 641	maximum normal value
R5	Equivalent-To Arg1:E34 Arg2:E5	
T91	Observation 642 666	alanine aminotransferase
E36	Observation:T91 Name:T92 Eq-Comparison:E38 Temporality:E13
T92	Observation-Name 642 666	alanine aminotransferase
A32	Observation-Type-Value T92 lab
T93	Observation 670 696	aspartate aminotransferase
E37	Observation:T93 Name:T94 Eq-Comparison:E38 Temporality:E13
T94	Observation-Name 670 696	aspartate aminotransferase
A33	Observation-Type-Value T94 lab
T95	Eq-Comparison 697 725	< 2.5 X maximum normal value
E38	Eq-Comparison:T95 Value:T98 Operator:T97 Unit:T99
T96	Or 667 669	or
E39	Or:T96 Arg:E36 Arg2:E37
T97	Eq-Operator 697 698	<
A34	Eq-Operator-Value T97 LT
T98	Eq-Value 699 702	2.5
T99	Eq-Unit 705 725	maximum normal value
A35	Eq-Unit-Value T90 ref-range-normal
A36	Eq-Unit-Value T99 ref-range-normal
T100	Condition 762 783	gross recurrent tumor
E40	Condition:T100 Name:T101
T101	Condition-Name 762 783	gross recurrent tumor
T102	Condition 809 819	metastasis
E41	Condition:T102 Name:T103 Temporality:E58
T103	Condition-Name 809 819	metastasis
T104	Condition 847 857	metastasis
E42	Condition:T104 Name:T105
T105	Condition-Name 847 857	metastasis
T106	Procedure 881 892	irradiation
E43	Procedure:T106 Name:T107 Temporality:E56
T107	Procedure-Name 881 892	irradiation
T108	Procedure 909 920	cryotherapy
E44	Procedure:T108 Name:T109 Temporality:E57
T109	Procedure-Name 909 920	cryotherapy
T110	Procedure 924 937	brachytherapy
E45	Procedure:T110 Name:T111
T111	Procedure-Name 924 937	brachytherapy
T112	Or 921 923	or
E46	Or:T112 Arg:E44 Arg2:E45
T113	Condition 951 957	cancer
E47	Condition:T113 Name:T114
T114	Condition-Name 951 957	cancer
R6	Treatment-For Arg1:E45 Arg2:E47	
R7	Treatment-For Arg1:E44 Arg2:E47	
T115	Condition 978 984	cancer
E48	Condition:T115 Name:T116 Minimum-Count:E49
T116	Condition-Name 978 984	cancer
T117	Eq-Comparison 963 969	Double
E49	Eq-Comparison:T117 Value:T118
T118	Eq-Value 963 969	Double
T119	Modifier 996 1000	skin
E50	Modifier:T119 Modifies:E52
T120	Modifier 1001 1008	thyroid
E51	Modifier:T120 Modifies:E52
T121	Condition 1009 1015	cancer
E52	Condition:T121 Name:T123
T122	Or 1000 1001	/
E53	Or:T122 Arg:E50 Arg2:E51
T123	Condition-Name 1009 1015	cancer
T124	Exception 985 995	other than
E54	Exception:T124 From:E48 Except:E52
T125	Condition 1038 1047	morbidity
E55	Condition:T125 Name:T126 Severity:T127
T126	Condition-Name 1038 1047	morbidity
T127	Severity 1030 1037	serious
A37	Severity-Value T127 severe
T128	Eq-Comparison 863 870	History
E56	Eq-Comparison:T128 Temporal-Period:T129
T129	Eq-Temporal-Period 863 870	History
A38	Eq-Temporal-Period-Value T129 past
T130	Eq-Comparison 898 905	History
E57	Eq-Comparison:T130 Temporal-Period:T131
T131	Eq-Temporal-Period 898 905	History
A39	Eq-Temporal-Period-Value T131 past
T132	Eq-Comparison 789 797	Presence
E58	Eq-Comparison:T132 Temporal-Period:T133
T133	Eq-Temporal-Period 789 797	Presence
A40	Eq-Temporal-Period-Value T133 present
T134	Eq-Comparison 825 833	Presence
E59	Eq-Comparison:T134 Temporal-Period:T135
T135	Eq-Temporal-Period 825 833	Presence
A41	Eq-Temporal-Period-Value T135 present
T136	Modifier 837 846	pelvic LN
E60	Modifier:T136 Modifies:T105
T137	Modifier 801 808	distant
E61	Modifier:T137 Modifies:T103
T138	Modifier 874 880	pelvic
E62	Modifier:T138 Modifies:T107
T139	Modifier 942 950	prostate
E63	Modifier:T139 Modifies:T114
T140	Modifier 970 977	primary
E64	Modifier:T140 Modifies:T116
